A new breast cancer test – Oncotype DX – that could spare thousands of women the ordeal of chemotherapy has been approved – by the National Institute for Health and Care Excellence (NICE) – for use in the NHS in England and Wales.
The test works out the odds of a some tumours spreading round the body and should help doctors decide more accurately which patients will need chemotherapy.
Read ‘Chemotherapy-sparing’ test offered, by James Gallagher, BBC News, 26 Sept 2013
Sources: Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat
NICE, September 2013
DES and Breast Cancer:
- Breast Cancer Screening in Women exposed in Utero to DiEthylStilbestrol.
- Prenatal DiEthylStilbestrol Exposure and Risk of Breast Cancer.
- Risk of Breast Cancer in Women exposed to DiEthylStilbestrol in Utero.
- DES studies on cancers and screening.
A DES Daughter's Blog 
Reblogged this on Laitom's Blog.
Tom
thanks a lot Tom
Reblogged this on larrymatthews.
Larry
Thanks Larry